中国防疫优质产品全球合作推介会在京圆满举行
The Global Cooperation Presentation for China's High-quality Epidemic Products Successfully Held in Beij
2022年1月21日下午，由驻华使节商务联盟主办，世界商人网协作，杰雅国际承办的【全球抗疫. 彰显中国力量】中国防疫优质产品全球合作推介会在联盟总部圆满举行。来自尼泊尔、摩尔多瓦、俄罗斯、哈萨克斯坦、布基纳法索、印度尼西亚等各国驻华大使馆使节、俄罗斯统一俄罗斯党北京中心商务代表、巴基斯坦国民银行中国首席代表、中国墨西哥商会资深专家、肯尼亚驻华商务代表及国内企业家代表近30人出席了主题推介活动。
On the afternoon of January 21, 2022, hosted by ECCAC with collaboration of the Global Merchant network.com.cn and organized by Smart ACE International（Operating Agency of ECCAC）, the global cooperation promotion event of "Global Anti Epidemic with the Power of China” was successfully held at the ECCAC headquarter. More than 30 guests attended the theme event, including officials from embassies of Nepal, Moldova, Russia, Kazakhstan, Burkina Faso, Indonesia and other countries in China, business representative of the Beijing Center of the Russian United Russia Party, Chief Representative of National Bank of Pakistan Representative Office Beijing, senior experts of the China Mexico Chamber of Commerce, business representatives of Kenya in China and representatives of domestic entrepreneurs.
世界商人网总编发言
Ms. Mairrsa Wang, Chief Editor of the Global Mechant
驻华使节商务联盟秘书长孙丽丽女士首先致辞，欢迎出席活动的各国使节嘉宾及中外商业代表。她强调ECCAC一如既往，继续加大各国与中国在各领域和产业发展的合作共赢，其中医疗健康产业尤为重要。希望大家天天健康。驻华使节商务联盟运营机构杰雅国际总裁王开先生随后致辞介绍联盟商务运营情况以及新冠疫情发展以来杰雅国际对世界各国积极参与疫情工作配送和捐赠的情况说明。
Ms. Lilly Sun, Secretary General of ECCAC, first delivered a speech to welcome official guests, and business representatives at home and abroad attending the event. She stressed that ECCAC, as always, will continue to increase win-win cooperation between countries and China in various fields and industrial development, especially the medical and health industry. She hoped everyone in good healthy every day. Mr. Kevin Wang, President of Smart ACE International (Operating Agency of ECCAC), then gave a brief introduction of ECCAC, as well as the description of the world's active participation in the distribution and donation of the medical materials and equipment back to outbreak of COVID-19.
紧跟新冠疫情发展的态势为世界防范新冠变异病毒，此次推介活动特别并有效推介了Wisetest“新一代Rapix唾液新冠抗原检测试剂盒”、英诺特INNOVITA新冠抗原检测试剂盒和创新特效抗新冠中草药-莲花清瘟三款优质产品。三家企业负责人对产品的使用情况以及时效性进行了详细的介绍并给予视频演示。参会各国使节及中外嘉宾随后对三款产品做了现场的测试，测试效果显著。
Following closely the development trend of COVID-19 to prevent the new crown variation virus in the world, the promotion activity has especially and effectively introduced three high-quality products, including Wisetest the "new Generation Saliva SARS-Covid -9 Antigen Test Kit", INNOVITA new antigen detection kit and the innovative special effect new crown Chinese traditional medicine Lianhua Qingwen. The heads of the three enterprises introduced the use and timeliness of the products in detail and gave video demonstrations. Officials from various countries and guests at home and abroad conducted on-site tests on the three products, and the test results were remarkable.
与会各国使节对于ECCAC举办的此次活动大加赞赏，感谢联盟组织此次极具价值的推介会。珍惜生命，保持健康是所有国家的人们最高的维护目标。大家同时也对抗击疫情的持续性工作表示大力的参与和支持。
Officials of embassies and guests presence expressed great appreciation to ECCAC for organizing this valuable promotional event. Cherishing life and keeping healthy is the highest maintenance goal of people in all countries worldwide. At the same time, everyone also shown strong positive attitude for support to the sustained work of combating the epidemic.
尼泊尔公使发言
Speech by Economic Minister of Nepal
肯尼亚商务代表发言
Speech by Business Representative of Kenya
本次“全球抗疫彰显中国力量”防疫产品全球合作推介会效果积极，推动了全球抗疫医用产品全球合作的新篇章，抗击病毒，全球共美好！
The "Global Anti Epidemic with the Power of China” has achieved positive results, promoting a new chapter of global cooperation in global anti epidemic medical products, fighting viruses and sharing a better world.
三家企业简介
Brief Introduction of Enterprises
嘉兴唯通生物技术有限公司是VALTE国际公司的全资子公司，位于美国加利福尼亚旧金山湾区。总生产面积约25000平方米。公司不仅拥有现代化的十万级清洁生产车间和一万级实验室。开发生产自测电晕抗原检测试剂盒、药物检测试剂盒、排卵试验和妊娠试验。
Jiaxing WiseTest Bio-Tech Co., Ltd. is a wholly-owned subsidiary of VALTE International Inc. located in San Francisco Bay Area, California, USA. With a total production space of about 25,000 square meters. Company not only has a modern hundred thousand grade cleanliness production workshop and ten thousand grade laboratory.Develop and produce of Self Test Corona Antigen Detection Kit, Drug Test Kit, Ovulaon Test and Pregnancy Test
INNOVITA北京英诺特生物技术股份有限公司（连同其子公司合称“英诺特”）是专注于POCT体外诊断产品研发、生产、销售的生物技术公司，下设英诺特（唐山）生物技术有限公司。目前英诺特生物产品已覆盖呼吸道系列、优生优育系列、肝炎系列、生殖系列、心血管系列、肾功能系列等多个检测领域，销售渠道覆盖全国各省区，并远销东南亚、中东、非洲、拉美、欧盟等海外地区。英诺特秉承以用户为中心的企业经营理念，为用户提供更准确、更便捷的产品和服务，用户的需求就是英诺特的追求。
Innovita Biological Technology Co., Ltd. (together with its subsidiaries, collectively known as “INNOVITA",) is a biotechnology company focusing on the research, development, production and sales of in vitro diagnostic POCT products. It consists of Innovita (Tangshan) , Innovita (Beijing) and Innovita (Guangzhou). NNOVITA has built six technical platforms such as antigen & antibody preparation, virus culture, colloidal gold, ELISA, fluorescence chromatography, immunofluorescence, and undertakes Chinese National High-tech R&D Program in the field of national major infectious diseases research and many other public health projects. Besides, INNOVITA has over ten national invention patents and sets up Beijing R&D center, Guangzhou R&D center, Hebei production base. With large clean workshops, and setting up colloidal gold, ELISA, fluorescence chromatography, PCR, immunofluorescence production lines, INNOVITA has obtained CE and ISO13485 certification.
石家庄以岭药业股份有限公司是国家重点高新技术企业，于1992年6月16日创建，公司以“继承创新、造福人类”为企业宗旨，以“科技健康明天”为企业发展目标，以健康人类为己任，造福社会为弘愿，始终坚持市场龙头、科技驱动的创新发展战略，以中医学术创新带动中医药产业化，运用现代高新技术研发中药、西药和生物药。创立“理论-临床-科研-产业-教学”五位一体的独特运营模式。先后承担两项国家973、国家863、国家自然科学基金、国家重点研发计划等国家级、省部级课题四十余项，研发治疗冠心病、脑梗塞的通心络胶囊，快慢兼治心律失常的参松养心胶囊，标本兼治慢性心衰的芪苈强心胶囊、治感冒抗流感的连花清瘟胶囊等专利新药10余个，截至2020年12月31日获得专利660项，荣获国家科技进步一等奖、国家科技进步二等奖、国家技术发明二等奖等国家级、省部级科技奖励三十余项。公司在河北石家庄、衡水，北京大兴、密云等地建设的生产基地，打造了完美的生产布局，保证了产品供应，引进国内外先进设备和制药工艺，打造符合国际标准的全面质量控制体系，保证了消费者的用药安全，建立了强大的营销网络与学术营销队伍，形成了科技中药、化生药、健康产业三大业务板块，在医药行业领域的影响力持续增长，为中国中药10强企业、中国医药上市20强企业、中国上市公司市值500强企业（股票代码002603）。
Yiling Pharmaceutical was established on June 16th, 1992. Originally it was only a small clinic called “Shijiazhuang Development Zone Medical Research Institute”. After years of fast development, it has grown into a listed company in Shenzhen Stock Exchange with 7 billion Yuan of net asset and 30 billion Yuan of market value. As a company with more than 10,000 employees, Yiling Pharmaceutical has made a protruding contribution to social and economic development. Due to the comprehensive strength, Yiling Pharmaceutical has won many honorary titles such as National Key Hi-tech Enterprise, Top 20 Listed Pharmaceutical Company, etc. Yiling Trademark has won the title of “China Famous Brand”.